Ranolazine
( DrugBank: Ranolazine / KEGG DRUG: Ranolazine, Ranolazine hydrochloride )
7 diseases
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 97 | 潰瘍性大腸炎 | 1 |
| 113 | 筋ジストロフィー | 1 |
| 114 | 非ジストロフィー性ミオトニー症候群 | 1 |
2. 筋萎縮性側索硬化症
臨床試験数 : 786 / 薬物数 : 550 - (DrugBank : 182) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 232
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
58. 肥大型心筋症
臨床試験数 : 181 / 薬物数 : 136 - (DrugBank : 40) / 標的遺伝子数 : 49 - 標的パスウェイ数 : 187
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
86. 肺動脈性肺高血圧症
臨床試験数 : 1,288 / 薬物数 : 565 - (DrugBank : 126) / 標的遺伝子数 : 81 - 標的パスウェイ数 : 191
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
96. クローン病
臨床試験数 : 2,737 / 薬物数 : 1,197 - (DrugBank : 240) / 標的遺伝子数 : 182 - 標的パスウェイ数 : 221
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
97. 潰瘍性大腸炎
臨床試験数 : 3,305 / 薬物数 : 1,646 - (DrugBank : 318) / 標的遺伝子数 : 165 - 標的パスウェイ数 : 220
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
113. 筋ジストロフィー
臨床試験数 : 766 / 薬物数 : 477 - (DrugBank : 119) / 標的遺伝子数 : 80 - 標的パスウェイ数 : 178
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
114. 非ジストロフィー性ミオトニー症候群
臨床試験数 : 13 / 薬物数 : 14 - (DrugBank : 4) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 9
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|